Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hoffmanová

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vnitrni Lekarstvi|December 20, 2013
[Serious risk related to oral use of sodium phosphate solution]I Hoffmanová, M Anděl
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|October 31, 2015
[Bone and Joint Involvement in Celiac Disease]I Hoffmanová, D Sánchez, V Džupa
Physiological Research|May 26, 2022
Serological markers of intestinal barrier impairment do not correlate with duration of diabetes and glycated hemoglobin in adult patients with type 1 and type 2 diabetes mellitusI Hoffmanová, D Sánchez, A Szczepanková, et al.
Physiological Research|December 4, 2014
Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2I Hoffmanová, D Sánchez, V Hábová, et al.
Physiological Research|May 12, 2018
Occurrence of serum antibodies against wheat alpha-amylase inhibitor 0.19 in celiac diseaseD Sánchez, S Štěpánová Honzová, M Hospodková, et al.
Clinical and Experimental Immunology|December 25, 2009
Calreticulin is a B cell molecular target in some gastrointestinal malignanciesA Pekáriková, D Sánchez, L Palová-Jelínková, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vnitrni Lekarstvi|December 20, 2013
[Serious risk related to oral use of sodium phosphate solution]I Hoffmanová, M Anděl
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|October 31, 2015
[Bone and Joint Involvement in Celiac Disease]I Hoffmanová, D Sánchez, V Džupa
Physiological Research|May 26, 2022
Serological markers of intestinal barrier impairment do not correlate with duration of diabetes and glycated hemoglobin in adult patients with type 1 and type 2 diabetes mellitusI Hoffmanová, D Sánchez, A Szczepanková, et al.
Physiological Research|December 4, 2014
Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2I Hoffmanová, D Sánchez, V Hábová, et al.
Physiological Research|May 12, 2018
Occurrence of serum antibodies against wheat alpha-amylase inhibitor 0.19 in celiac diseaseD Sánchez, S Štěpánová Honzová, M Hospodková, et al.
Clinical and Experimental Immunology|December 25, 2009
Calreticulin is a B cell molecular target in some gastrointestinal malignanciesA Pekáriková, D Sánchez, L Palová-Jelínková, et al.
Pageof 1